Altogether, our results suggest that in tumor cells, Sdc-1 KD decreases the expression of angiogenic factors, in a mechanism that could involve several pro-angiogenic molecules such as VEGF, PDGF, IL-8, and miR10b. Here, SDC1 is linked to neoplasm.